Cargando…
Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
Rifaximin has only been rarely reported to cause rhabdomyolysis. When physical and nonphysical etiologies have been excluded, thorough review of the patient’s medication list is necessary. In cirrhotics, the potential harm of rifaximin in treatment or prophylaxis of hepatic encephalopathy should be...
Autores principales: | Rezigh, Alec B., Armenia, Erin, Li, Ting, Soesilo, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028404/ https://www.ncbi.nlm.nih.gov/pubmed/29988652 http://dx.doi.org/10.1002/ccr3.1583 |
Ejemplares similares
-
Catching the diagnosis: A peculiar presentation of Chiari malformation type I
por: Rezigh, Austin C., et al.
Publicado: (2023) -
The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021) -
An uncommon culprit of neutropenic fever: a case of Sweet syndrome following induction therapy for acute myeloid leukemia
por: Alderazi, Ahmed, et al.
Publicado: (2023) -
Rifaximin has the potential to prevent complications of
cirrhosis
por: Flamm, Steven L., et al.
Publicado: (2018) -
A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
por: Rawla, Prashanth, et al.
Publicado: (2019)